These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25407935)

  • 1. Carotid artery infusions for pharmacokinetic and pharmacodynamic analysis of taxanes in mice.
    Jacobs JD; Hopper-Borge EA
    J Vis Exp; 2014 Oct; (92):e51917. PubMed ID: 25407935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of an occlusion perfusion catheter to deliver paclitaxel to the arterial wall.
    Atigh MK; Turner E; Christians U; Yazdani SK
    Cardiovasc Ther; 2017 Aug; 35(4):. PubMed ID: 28445625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.
    Wang X; Deng L; Chen X; Pei H; Cai L; Zhao X; Wei Y; Chen L
    J Pharm Sci; 2011 Mar; 100(3):1196-205. PubMed ID: 20860011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion.
    Ohtsu T; Sasaki Y; Tamura T; Miyata Y; Nakanomyo H; Nishiwaki Y; Saijo N
    Clin Cancer Res; 1995 Jun; 1(6):599-606. PubMed ID: 9816021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastases.
    Siqing F; Culotta KS; Falchook GS; Hong DS; Myers AL; Zhang YP; Naing A; Janku F; Hou MM; Kurzrock R
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):357-64. PubMed ID: 26698868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings.
    Damascelli B; Patelli GL; Lanocita R; Di Tolla G; Frigerio LF; Marchianò A; Garbagnati F; Spreafico C; Tichà V; Gladin CR; Palazzi M; Crippa F; Oldini C; Calò S; Bonaccorsi A; Mattavelli F; Costa L; Mariani L; Cantù G
    AJR Am J Roentgenol; 2003 Jul; 181(1):253-60. PubMed ID: 12818869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.
    Bulitta JB; Zhao P; Arnold RD; Kessler DR; Daifuku R; Pratt J; Luciano G; Hanauske AR; Gelderblom H; Awada A; Jusko WJ
    Cancer Chemother Pharmacol; 2009 May; 63(6):1049-63. PubMed ID: 18791718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirect-response model for the time course of leukopenia with anticancer drugs.
    Minami H; Sasaki Y; Saijo N; Ohtsu T; Fujii H; Igarashi T; Itoh K
    Clin Pharmacol Ther; 1998 Nov; 64(5):511-21. PubMed ID: 9834043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of paclitaxel in an anephric patient.
    Woo MH; Gregornik D; Shearer PD; Meyer WH; Relling MV
    Cancer Chemother Pharmacol; 1999; 43(1):92-6. PubMed ID: 9923547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay.
    Gustafson DL; Long ME; Zirrolli JA; Duncan MW; Holden SN; Pierson AS; Eckhardt SG
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):159-66. PubMed ID: 12759775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interleukin-2 pretreatment on paclitaxel absorption and tissue disposition after oral and intravenous administration in mice.
    Hosten B; Abbara C; Petit B; Dauvin A; Bourasset F; Farinotti R; Gonin P; Bonhomme-Faivre L
    Drug Metab Dispos; 2008 Aug; 36(8):1729-35. PubMed ID: 18508881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel delivery to brain tumors from hydrogels: a computational study.
    Torres AJ; Zhu C; Shuler ML; Pannullo S
    Biotechnol Prog; 2011; 27(5):1478-87. PubMed ID: 21786432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of a 1-h paclitaxel infusion.
    Mross K; Holländer N; Hauns B; Schumacher M; Maier-Lenz H
    Cancer Chemother Pharmacol; 2000; 45(6):463-70. PubMed ID: 10854133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
    Liu J; Kraut EH; Balcerzak S; Grever M; D'Ambrosio S; Chan KK
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule.
    Jang SH; Wientjes MG; Au JL
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1035-42. PubMed ID: 11181938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer.
    Mielke S; Sparreboom A; Steinberg SM; Gelderblom H; Unger C; Behringer D; Mross K
    Clin Cancer Res; 2005 Jul; 11(13):4843-50. PubMed ID: 16000582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and safety of bevacizumab administered in combination with cisplatin and paclitaxel in cynomolgus monkeys.
    Xu L; Zuch CL; Lin YS; Modi NB; Lum BL
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):607-14. PubMed ID: 17549476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles.
    van Zuylen L; Karlsson MO; Verweij J; Brouwer E; de Bruijn P; Nooter K; Stoter G; Sparreboom A
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):309-18. PubMed ID: 11345647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients.
    Bulitta JB; Zhao P; Arnold RD; Kessler DR; Daifuku R; Pratt J; Luciano G; Hanauske AR; Gelderblom H; Awada A; Jusko WJ
    Cancer Chemother Pharmacol; 2009 May; 63(6):1035-48. PubMed ID: 18791717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.